{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:46:17Z","timestamp":1792449977149,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"vor","delay-in-days":3702,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Clinical Nutrition"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.3945\/ajcn.112.036319","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T04:37:04Z","timestamp":1354163824000},"page":"37-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Effect of omega-3 (n\u22123) fatty acid supplementation in patients with sickle cell anemia: randomized, double-blind, placebo-controlled trial"],"prefix":"10.1016","volume":"97","author":[{"given":"Ahmed A","family":"Daak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kebreab","family":"Ghebremeskel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahir","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bakhita","family":"Attallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haj H","family":"Azan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa I","family":"Elbashir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3945\/ajcn.112.036319_bib1","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"key":"10.3945\/ajcn.112.036319_bib2","series-title":"Sickle cell disease.","author":"Serjeant","year":"2001"},{"key":"10.3945\/ajcn.112.036319_bib3","series-title":"Disease control priorities in developing countries.","first-page":"663","article-title":"Inherited disorders of hemoglobin","author":"Weatherall","year":"2006"},{"key":"10.3945\/ajcn.112.036319_bib4","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2471\/BLT.06.036673","article-title":"Global epidemiology of haemoglobin disorders and derived service indicators","volume":"86","author":"Modell","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.3945\/ajcn.112.036319_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/sj.thj.6200147","article-title":"Patterns of mortality in sickle cell disease in adults in France and England","volume":"3","author":"Perronne","year":"2002","journal-title":"Hematol J"},{"key":"10.3945\/ajcn.112.036319_bib6","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"key":"10.3945\/ajcn.112.036319_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ajh.21550","article-title":"Definitions of the phenotypic manifestations of sickle cell disease","volume":"85","author":"Ballas","year":"2010","journal-title":"Am J Hematol"},{"key":"10.3945\/ajcn.112.036319_bib8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/ncpneuro0495","article-title":"Therapy insight: stroke risk and its management in patients with sickle cell disease","volume":"3","author":"Kirkham","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"key":"10.3945\/ajcn.112.036319_bib9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1467-7687.2006.00503.x","article-title":"Physiological correlates of intellectual function in children with sickle cell disease: hypoxaemia, hyperaemia and brain infarction","volume":"9","author":"Hogan","year":"2006","journal-title":"Dev Sci"},{"key":"10.3945\/ajcn.112.036319_bib10","first-page":"288","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors","volume":"91","author":"Ohene-Frempong","year":"1998","journal-title":"Blood"},{"key":"10.3945\/ajcn.112.036319_bib11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejrad.2009.05.032","article-title":"Cranial involvement in sickle cell disease","volume":"76","author":"Alkan","year":"2010","journal-title":"Eur J Radiol"},{"key":"10.3945\/ajcn.112.036319_bib12","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.puhe.2007.12.005","article-title":"Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: lessons from pilot studies","volume":"122","author":"Tshilolo","year":"2008","journal-title":"Public Health"},{"key":"10.3945\/ajcn.112.036319_bib13","doi-asserted-by":"crossref","first-page":"e14699","DOI":"10.1371\/journal.pone.0014699","article-title":"Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania","volume":"6","author":"Makani","year":"2011","journal-title":"PLoS ONE"},{"key":"10.3945\/ajcn.112.036319_bib14","first-page":"492","article-title":"Pathophysiology and treatment of sickle cell disease","volume":"3","author":"Raphael","year":"2005","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.3945\/ajcn.112.036319_bib15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00043426-199305000-00010","article-title":"The reversibly sickled cell","volume":"15","author":"Zipursky","year":"1993","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.3945\/ajcn.112.036319_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00062752-199903000-00003","article-title":"Thrombosis in heritable hemolytic disorders","volume":"6","author":"Barker","year":"1999","journal-title":"Curr Opin Hematol"},{"key":"10.3945\/ajcn.112.036319_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tracli.2008.04.009","article-title":"Role and regulation of sickle red cell interactions with other cells: ICAM-4 and other adhesion receptors","volume":"15","author":"Zennadi","year":"2008","journal-title":"Transfus Clin Biol"},{"key":"10.3945\/ajcn.112.036319_bib18","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJM198005013021803","article-title":"Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity","volume":"302","author":"Hebbel","year":"1980","journal-title":"N Engl J Med"},{"key":"10.3945\/ajcn.112.036319_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10739680802279394","article-title":"Sickle red cell-endothelium interactions","volume":"16","author":"Kaul","year":"2009","journal-title":"Microcirculation"},{"key":"10.3945\/ajcn.112.036319_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0268-960X(96)90018-1","article-title":"The pathophysiology of vascular obstruction in the sickle syndromes","volume":"10","author":"Kaul","year":"1996","journal-title":"Blood Rev"},{"key":"10.3945\/ajcn.112.036319_bib21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/01.moh.0000190108.62414.06","article-title":"Leukocyte adhesion and the pathophysiology of sickle cell disease","volume":"13","author":"Okpala","year":"2006","journal-title":"Curr Opin Hematol"},{"key":"10.3945\/ajcn.112.036319_bib22","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1172\/JCI30920","article-title":"Sickle cell disease: old discoveries, new concepts, and future promise","volume":"117","author":"Frenette","year":"2007","journal-title":"J Clin Invest"},{"key":"10.3945\/ajcn.112.036319_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0005-2736(93)90216-M","article-title":"Effects of dietary fatty-acid supplementation on fatty-acid composition and deformability of young and old erythrocytes","volume":"1149","author":"Mills","year":"1993","journal-title":"Biochim Biophys Acta"},{"key":"10.3945\/ajcn.112.036319_bib24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1388-1981(00)00082-2","article-title":"Arachidonic acid-containing phosphatidylcholine inhibits lymphocyte proliferation and decreases interleukin-2 and interferon-gamma production from concanavalin A-stimulated rat lymphocytes","volume":"1487","author":"Nishiyama","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.3945\/ajcn.112.036319_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0305-0491(90)90196-Z","article-title":"N-3 and N-6 phosphoglyceride fatty acids in relation to in vitro erythrocyte haemolysis induced by hydrogen peroxide in captive common marmosets (Callithrix jacchus)","volume":"97","author":"Harbige","year":"1990","journal-title":"Comp Biochem Physiol B"},{"key":"10.3945\/ajcn.112.036319_bib26","doi-asserted-by":"crossref","first-page":"8491","DOI":"10.1073\/pnas.0402531101","article-title":"Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress","volume":"101","author":"Mukherjee","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.3945\/ajcn.112.036319_bib27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/00365519309090699","article-title":"The effect of dietary N-3 fatty acids on osmotic fragility and membrane fluidity of human erythrocytes","volume":"215","author":"Hagve","year":"1993","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"10.3945\/ajcn.112.036319_bib28","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/jn\/121.4.547","article-title":"Oral (n\u22123) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women","volume":"121","author":"Meydani","year":"1991","journal-title":"J Nutr"},{"key":"10.3945\/ajcn.112.036319_bib29","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s00277-005-1023-7","article-title":"Blood mononuclear cells and platelets have abnormal fatty acid composition in homozygous sickle cell disease","volume":"84","author":"Ren","year":"2005","journal-title":"Ann Hematol"},{"key":"10.3945\/ajcn.112.036319_bib30","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1016\/S0022-2275(20)30036-5","article-title":"Abnormal phospholipid molecular species of erythrocytes in sickle cell anemia","volume":"38","author":"Connor","year":"1997","journal-title":"J Lipid Res"},{"key":"10.3945\/ajcn.112.036319_bib31","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1055\/s-0037-1615948","article-title":"Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n\u22123 fatty acids","volume":"85","author":"Tomer","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.3945\/ajcn.112.036319_bib32","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1600-0463.2011.02751.x","article-title":"Pilot study of omega-3 fatty acid supplements in sickle cell disease","volume":"119","author":"Okpala","year":"2011","journal-title":"APMIS"},{"key":"10.3945\/ajcn.112.036319_bib33","doi-asserted-by":"crossref","first-page":"718014","DOI":"10.1155\/2011\/718014","article-title":"Hydroxyurea therapy mobilises arachidonic acid from inner cell membrane aminophospholipids in patients with homozygous sickle cell disease.","volume":"2011","author":"Daak","year":"2011","journal-title":"J Lipids"},{"key":"10.3945\/ajcn.112.036319_bib34","series-title":"Sickle cell disease.","author":"Serjeant","year":"1985"},{"key":"10.3945\/ajcn.112.036319_bib35","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1161\/01.STR.0000130856.31468.47","article-title":"Fish consumption and incidence of stroke: a meta-analysis of cohort studies","volume":"35","author":"He","year":"2004","journal-title":"Stroke"},{"key":"10.3945\/ajcn.112.036319_bib36","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4103\/1117-1936.175263","article-title":"Changes in erythrocytes following supplementation with alpha-tocopherol in children suffering from sickle cell anaemia","volume":"12","author":"Jaja","year":"2005","journal-title":"Niger Postgrad Med J"},{"key":"10.3945\/ajcn.112.036319_bib37","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s11745-006-0984-1","article-title":"EPA, but not DHA, decreases mean platelet volume in normal subjects","volume":"37","author":"Park","year":"2002","journal-title":"Lipids"},{"key":"10.3945\/ajcn.112.036319_bib38","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s11745-999-0481-6","article-title":"Effects of eicosapentaenoic acid and docosahexaenoic acid on plasma membrane fluidity of aortic endothelial cells","volume":"34","author":"Hashimoto","year":"1999","journal-title":"Lipids"},{"key":"10.3945\/ajcn.112.036319_bib39","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.plefa.2005.03.005","article-title":"Steady-state haemoglobin level in sickle cell anaemia increases with an increase in erythrocyte membrane n\u22123 fatty acids","volume":"72","author":"Ren","year":"2005","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.3945\/ajcn.112.036319_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plefa.2005.10.002","article-title":"Abnormality of erythrocyte membrane n\u22123 long chain polyunsaturated fatty acids in sickle cell haemoglobin C (HbSC) disease is not as remarkable as in sickle cell anaemia (HbSS)","volume":"74","author":"Ren","year":"2006","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.3945\/ajcn.112.036319_bib41","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1111\/j.1651-2227.2010.01940.x","article-title":"Milk of northern Sudanese mothers whose traditional diet is high in carbohydrate contains low docosahexaenoic acid","volume":"99","author":"Nyuar","year":"2010","journal-title":"Acta Paediatr"},{"key":"10.3945\/ajcn.112.036319_bib42","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1079\/NRR200497","article-title":"The impact of long-chain n\u22123 polyunsaturated fatty acids on human health","volume":"18","author":"Ruxton","year":"2005","journal-title":"Nutr Res Rev"},{"key":"10.3945\/ajcn.112.036319_bib43","doi-asserted-by":"crossref","first-page":"H811","DOI":"10.1152\/ajpheart.00235.2002","article-title":"Omega-3 fatty acids suppress monocyte adhesion to human endothelial cells: role of endothelial PAF generation","volume":"283","author":"Mayer","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["The American Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523053704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523053704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ajcn\/article-pdf\/97\/1\/37\/23818492\/37.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T17:41:36Z","timestamp":1728495696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002916523053704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0002916523053704"],"URL":"https:\/\/doi.org\/10.3945\/ajcn.112.036319","relation":{},"ISSN":["0002-9165"],"issn-type":[{"value":"0002-9165","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of omega-3 (n\u22123) fatty acid supplementation in patients with sickle cell anemia: randomized, double-blind, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3945\/ajcn.112.036319","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Nutrition. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}